Paulson John 4

What Happened John Paulson, a director of Bausch Health Companies Inc., was granted 12,677 restricted share units (RSUs) on 2026-06-30. The reported grant price/value was $4.93 per share, for a total reported value of $62,498. This was an award issued in lieu of cash compensation for board service (an award/grant, not a purchase or sale).

Key Details

• Transaction date: 2026-06-30; Filing date (Form 4): 2026-07-02 (appears timely).
• Transaction type/code: A (award/grant of RSUs).
• Shares/units: 12,677 RSUs at $4.93 each; total reported value $62,498.
• Shares owned after transaction: Not disclosed in this Form 4.
• Footnotes: F1 — RSUs issued in lieu of cash compensation, each representing a contingent right to one common share. F2 — John Paulson is the controlling person of Paulson Capital Inc.; he may be deemed an indirect beneficial owner of securities held by investment funds managed by Paulson, but he disclaims direct beneficial ownership except to the extent of any pecuniary interest.

Context RSUs are a form of compensation that convert to shares only upon vesting and are commonly used for board pay; they are not an open‑market purchase and do not necessarily indicate immediate buying or selling intent. The filing notes the award was for board service and includes the standard disclosure about indirect ownership through Paulson-managed funds.